Skip to main content

Hepatitis viruses

Section Editor: Alan McLachlan, University of Illinois at Chicago, USA 
Deputy Section Editor: Susan Uprichard, Loyola University Medical Center​​​​​​​, USA 

The Hepatitis viruses section of Virology Journal includes studies relating to all aspects of hepatitis A, B C, D and E virus research including research discoveries addressing both basic and medical aspects of the biology of these human pathogens. Basic research topics of interest include all aspects of the viral life cycle (e.g. viral entry, intracellular capsid transport and disassembly, viral gene expression/regulation, protein processing/regulation, viral genome replication, particle assembly and egress) and viral-host interactions. Medical research topics of interest include but are not limited to viral pathogenesis, epidemiology, immunology, therapies and emergence of drug-resistant variants.

Page 4 of 5

  1. Worldwide, Hepatitis C (HCV) infection has been increasingly recognized in HIV-positive men who have sex with men (MSM). The objective of this study was to characterize the transmission dynamics of acute HCV i...

    Authors: Denise P. Chan, Ada W. Lin, Ka Hing Wong, Ngai Sze Wong and Shui Shan Lee
    Citation: Virology Journal 2015 12:120
  2. Hepatitis C virus (HCV) genotype and subtype are related to disease progression and response to antiviral therapy. Current HCV genotype and subtype distribution data, especially for genotypes 3 and 6, are limi...

    Authors: Wei Ju, Song Yang, Shenghu Feng, Qi Wang, Shunai Liu, Huichun Xing, Wen Xie, Liying Zhu and Jun Cheng
    Citation: Virology Journal 2015 12:109
  3. Mixed cryoglobulinemia (MC) in hepatitis C virus (HCV) infection is associated with abnormal immune responses mediated by T cells and B cells, while the relationships of different subsets of CD4 + T helper (Th...

    Authors: Fanyun Kong, Wei Zhang, Bo Feng, Henghui Zhang, Huiying Rao, Jianghua Wang, Xu Cong and Lai Wei
    Citation: Virology Journal 2015 12:100
  4. Hepatitis C virus (HCV) genome contains two envelope proteins (E1 and E2) responsible for the virus entry into the cell. There is a substantial lack of sequences covering the full length of E1/E2 region for ge...

    Authors: Nehal Hussein, Abdel-Rahman N Zekri, Mohamed Abouelhoda, Hanaa M Alam El-din, Ahmed Abdelwahab Ghamry, Mahmoud A Amer, Ghada M sherif and Abeer A Bahnassy
    Citation: Virology Journal 2014 11:231
  5. Hepatitis E virus (HEV) has been reported in the human population and pigs are a recognized reservoir for HEV and a possible source of HEV transmission to humans. Spray-dried porcine plasma (SDPP) is an ingred...

    Authors: Joan Pujols, Carmen Rodríguez, Nuria Navarro, Sonia Pina-Pedrero, Joy M Campbell, Joe Crenshaw and Javier Polo
    Citation: Virology Journal 2014 11:232
  6. Hepatitis B virus (HBV) surface antigen (HBsAg) screening in blood banks reduced the risk of HBV transmission through transfusion. However, the detection of occult HBV infection among blood donors is imperativ...

    Authors: Wilson Alfredo Rios-Ocampo, Fabián Cortes-Mancera, Juan Camilo Olarte, Angela Soto and Maria-Cristina Navas
    Citation: Virology Journal 2014 11:206
  7. Hepatitis C virus (HCV) is a public health problem with almost 185 million people estimated to be infected worldwide and is one of the leading causes of hepatocellular carcinoma. Currently, there is no vaccine...

    Authors: Maemu P Gededzha, M Jeffrey Mphahlele and Selokela G Selabe
    Citation: Virology Journal 2014 11:187
  8. The antiviral therapy of chronic hepatitis B virus (HBV) infection pursues the dual goals, virological response (undetectable serum HBV DNA) and hepatitis B e antigen (HBeAg) serological response (serum HBeAg ...

    Authors: Hui Y Yang, Nai Q Zheng, Dong M Li, Lin Gu and Xiao M Peng
    Citation: Virology Journal 2014 11:165
  9. Hepatitis E is a disease of major public-health concern mainly in developing countries. Although molecular and sero-epidemiological investigations of HEV have been performed in many provinces in China, the epi...

    Authors: Xianghua Shu, Xinhui Duan, Chunlian Song, Jintao Li, Lei Jiang, Gefen Yin and Wengui Li
    Citation: Virology Journal 2014 11:162
  10. Substitutions of amino acid (aa) 70 in the core region of hepatitis C virus genotype 1b (HCV 1b) are a predictor of the non-virological response to pegylated interferon plus ribavirin (PEG-IFN/RBV) therapy. Th...

    Authors: Zhongjie Hu, Ying Liu, Lixia Qiu, Zuopeng Fan, Wei Nie, Shan Liang and Ronghua Jin
    Citation: Virology Journal 2014 11:148
  11. Aberrant DNA methylation profiles are a characteristic feature of almost all types of cancers including hepatocellular carcinoma (HCC) and play an important role in carcinogenesis. In spite of the accumulating...

    Authors: Muhammad Umer, Sohail Asif Qureshi, Zahid Yasin Hashmi, Asif Raza, Janbaz Ahmad, Moazur Rahman and Mazhar Iqbal
    Citation: Virology Journal 2014 11:117
  12. Hepatitis B (HB) is an important disease worldwide. Almost 350 million people are positive for Hepatitis B virus surface antigen (HBsAg), and one-third of them live in China. According to a nation-wide serosur...

    Authors: Xiaoming Chen, Jie Gao, Zhaohua Ji, Weilu Zhang, Lei Zhang, Rui Xu, Jingxia Zhang, Fei Li, Shi Li, Shijie Hu, Lei Shang, ZhongJun Shao and Yongping Yan
    Citation: Virology Journal 2014 11:101
  13. Torque Teno Virus (TTV) is a DNA virus with high rate of prevalence globally. Since its discovery in 1997, several studies have questioned the role of this virus in causing disease. However, it still remains a...

    Authors: Dhananjay Singh Mankotia and Mohammad Irshad
    Citation: Virology Journal 2014 11:96
  14. Study C210 was a Phase IIa, exploratory trial to assess the activity of telaprevir on hepatitis C virus (HCV) early viral kinetics in treatment-naïve patients infected with genotype 4 (G4) HCV.

    Authors: Sandra De Meyer, Anne Ghys, Inge Dierynck, Maria Beumont, Donghan Luo and Gaston Picchio
    Citation: Virology Journal 2014 11:93
  15. Hepatitis C virus (HCV) is a human pathogen causing chronic liver disease in about 200 million people worldwide. However, HCV resistance to interferon treatment is one of the important clinical implications, s...

    Authors: Xinliang Mao, Xifang Li, Xinjun Mao, Zhiwen Huang, Chengcheng Zhang, Wenjun Zhang, Jianguo Wu and Gang Li
    Citation: Virology Journal 2014 11:86
  16. Hepatitis E Virus (HEV) infection has a poor prognosis among pregnant women from high endemic countries. HEV-prevalence and incidence among pregnant women is unknown in high-income countries such as France. Th...

    Authors: Christophe Renou, Vincent Gobert, Christophe Locher, Abdelouahab Moumen, Oumar Timbely, Janine Savary and Anne-Marie Roque-Afonso
    Citation: Virology Journal 2014 11:68
  17. Currently, there is no consensus on the efficacy and resistance of de novo combination therapy versus monotherapy for treatment naive patients of chronic hepatitis B (CHB).

    Authors: Fen Liu, Xiwei Wang, Fang Wei, Huaidong Hu, Dazhi Zhang, Peng Hu and Hong Ren
    Citation: Virology Journal 2014 11:59
  18. Blood CXCR5+CD4+ T cells are defined as circulating T follicular helper (TFH) cells, which is required for effective humoral immunity. This study aimed to investigate the role of circulating TFH cells in patie...

    Authors: Ting-Ting Hu, Xiao-Fei Song, Yu Lei, Huai-Dong Hu, Hong Ren and Peng Hu
    Citation: Virology Journal 2014 11:54
  19. The suppressor of cytokine signaling family (SOCS) is an important negative regulator in the JAK-STAT signaling pathway. This study was designed to explore the correlation between SOCS-1, 2 and 3, Hepatitis B ...

    Authors: Ling-yao Du, Yao-li Cui, En-qiang Chen, Xing Cheng, Li Liu and Hong Tang
    Citation: Virology Journal 2014 11:51
  20. Hepatitis C virus is a persistent epidemiological problem, with an estimated 170 million individuals infected worldwide, and the leading cause of asymptomatic chronic infection, liver cirrhosis and hepatocellu...

    Authors: Roxana-Delia Trimbitas, Fatima Zahra Serghini, Fatiha Lazaar, Warda Baha, Abderrahim Foullous, Mohammed Essalhi, Abdelouahed El Malki, Abdelkrim Meziane Bellefquih and Abdelouaheb Bennani
    Citation: Virology Journal 2014 11:43
  21. Currently, sharing of drug paraphernalia is the main form of HCV transmission worldwide. In South America, consistent findings indicate that shared sniffing equipment is an important factor in the spread of HC...

    Authors: Aldemir B Oliveira-Filho, Leila Sawada, Laine C Pinto, Daiane Locks, Santana L Bahia, JairoA A Castro, Renata B Hermes, Igor Brasil-Costa, CarlosE M Amaral and José Alexandre R Lemos
    Citation: Virology Journal 2014 11:38
  22. Hepatitis B virus (HBV) transcription and replication are essentially restricted to hepatocytes. Based on the HBV enhancer and promoter complex that links hepatic glucose metabolism to its transcription and re...

    Authors: Xiaohui Tian, Fei Zhao, Weihua Sun, Xiaoguang Zhi, Zhikui Cheng, Ming Zhou and Kanghong Hu
    Citation: Virology Journal 2014 11:30
  23. Hepatitis C virus (HCV) is highly infectious pathogen which is responsible for causing Hepatitis around 200 million individuals worldwide. In Pakistan, 4.7% of HCV prevalence has been reported and HCV genotype...

    Authors: Suliman Qadir Afridi, Muhammad Muddassir Ali, Furqan Awan, Muhammad Nauman Zahid, Irfan Qadir Afridi, Sara Qadir Afridi and Tahir Yaqub
    Citation: Virology Journal 2014 11:24
  24. Currently there is a significant risk of infection with hepatitis B virus (HBV) during blood transfusion in high epidemic area. This is due to the pre-seroconversion window period, immunovariant viral strains ...

    Authors: Alcione de Oliveira dos Santos, Luan Felipo Botelho Souza, Lourdes Maria Borzacov, Juan Miguel Villalobos-Salcedo and Deusilene Souza Vieira
    Citation: Virology Journal 2014 11:16
  25. Co-infections with HBV (hepatitis B virus) occur in HIV (human immunodeficiency virus) patients frequently. It has been reported that an effective treatment of HIV can also lead to a suppression of HBV and to ...

    Authors: Rongjuan Pei, Sebastian Grund, Jens Verheyen, Stefan Esser, Xinwen Chen and Mengji Lu
    Citation: Virology Journal 2014 11:9
  26. Direct-acting antiviral (DAA) agents target HCV proteins; some of these have already been approved for the treatment of HCV infection, while others are in development. However, selection of DAA-resistant viral...

    Authors: Stefania Paolucci, Loretta Fiorina, Bianca Mariani, Roberto Gulminetti, Stefano Novati, Giorgio Barbarini, Raffaele Bruno and Fausto Baldanti
    Citation: Virology Journal 2013 10:355
  27. Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma and infects about 3% world population. Response to interferon therapy depends upon the genotype of the virus and factors...

    Authors: Atika Mansoor, Lubna Ali, Noor-ul Sabah, Asraf Hussain Hashmi, Mohammad Haroon Khan, Syed Ali Raza Kazmi, Nafees Ahmad, Saima Siddiqi and Khalid Mehmood Khan
    Citation: Virology Journal 2013 10:352
  28. Although hepatitis C virus (HCV) is primarily hepatotropic, markers of HCV replication were detected in peripheral blood mononuclear cells (PBMC) as well as in ex vivo collected tissues and organs. Specific strai...

    Authors: Agnieszka Pawełczyk, Natalia Kubisa, Joanna Jabłońska, Iwona Bukowska-Ośko, Kamile Caraballo Cortes, Maria Fic, Tomasz Laskus and Marek Radkowski
    Citation: Virology Journal 2013 10:346
  29. Using various methods, we analyzed the cause of death among weaned pigs from a pig farm in Hebei Province, China. All 300 piglets (100% fatality) were identified as moribund, with death occurring within 1 mont...

    Authors: Jingjing Mao, Yue Zhao, Ruiping She, Peng Xiao, Jijing Tian and Jian Chen
    Citation: Virology Journal 2013 10:341
  30. An animal model for HBV that more closely approximates the disease in humans is needed. The tree shrew (Tupaia belangeri) is closely related to primates and susceptible to HBV. We previously established that neon...

    Authors: Ping Ruan, Chun Yang, Jianjia Su, Ji Cao, Chao Ou, Chengpiao Luo, Yanping Tang, Qi Wang, Fang Yang, Junlin Shi, Xiaoxu Lu, Linqun Zhu, Hong Qin, Wen Sun, Yuanzhi Lao and Yuan Li
    Citation: Virology Journal 2013 10:333
  31. Continuous long-term treatment is recommended to reduce the hepatitis B virus (HBV) viral load. However, as a consequence, resistance mutations can emerge and be transmitted to other individuals. The polymeras...

    Authors: Nathalia Mantovani, Maira Cicero, Luiz Claudio Santana, Carla Silveira, Eliane Pereira do Carmo, Paulo Roberto Ferreira Abrão, Ricardo Sobhie Diaz, Marcos Montani Caseiro and Shirley Vasconcelos Komninakis
    Citation: Virology Journal 2013 10:320
  32. Antiviral drug-resistant HBV mutants are complex and currently partly understood. This study was performed to analyze the profile of hepatitis B virus (HBV) resistance mutations against nucleos(t)ide analogues...

    Authors: Jun Lei, Ying Wang, Li-Li Wang, Shao-Jun Zhang, Wei Chen, Zhi-Gang Bai and Lv-Ye Xu
    Citation: Virology Journal 2013 10:313
  33. Hepatitis B virus (HBV) induces proliferation of human mesangial cells (HMCs), and extracellular matrix expression through the deposition of immune complexes in renal tissue. However, it is unclear whether HBV...

    Authors: Zongli Diao, Jiaxiang Ding, Chenghong Yin, Liyan Wang and Wenhu Liu
    Citation: Virology Journal 2013 10:300
  34. The current standard of care (SOC) for hepatitis C virus (HCV) infection is the combination of pegylated interferon (PEG-IFN), Ribavirin and protease inhibitor for HCV genotype 1. Nevertheless, this treatment ...

    Authors: Muhammad Imran, Sobia Manzoor, Javed Ashraf, Madiha Khalid, Muqddas Tariq, Hafiza Madeha Khaliq and Sikandar Azam
    Citation: Virology Journal 2013 10:299
  35. CTL escape mutations have been described during acute hepatitis C in patients who developed chronic disease later on. Our aim was to investigate the mutual relationship between HCV specific CD8+ T cells and ev...

    Authors: Axel Ulsenheimer, Gláucia Paranhos-Baccalà, Florence Komurian-Pradel, Bijan Raziorrouh, Peter Kurktschiev, Helmut M Diepolder, Reinhart Zachoval, Michael Spannagl, Maria-Christina Jung and Norbert H Gruener
    Citation: Virology Journal 2013 10:295
  36. Selective pressure from either the immune response or the use of nucleoside analogs in antiviral therapy could be driving the emergence of HBV mutants. Because of the overlap of the open reading frame (ORF) S for...

    Authors: Mingshun Zhang, Guohong Ge, Yonglin Yang, Xubing Cai, Qiang Fu, Jie Cai and Zuhu Huang
    Citation: Virology Journal 2013 10:292
  37. Majority of previous studies of pegylated interferon α-2a (PegIFNα-2a) forced on naïve chronic hepatitis B (CHB) patients, and the data of PegIFNα-2a in therapy of patients with prior exposure to nucleos(t)ide...

    Authors: Min Weng, Wei-Zheng Zeng, Xiao-Ling Wu, Yong Zhang, Ming-De Jiang, Zhao Wang, De-Jiang Zhou and Xuan He
    Citation: Virology Journal 2013 10:277
  38. Hepatitis C virus (HCV) is a major cause of liver disease and a potential cause of substantial morbidity and mortality worldwide. The overall prevalence of HCV infection is 2%, representing 120 million people ...

    Authors: Tutik Sri Wahyuni, Lydia Tumewu, Adita Ayu Permanasari, Evhy Apriani, Myrna Adianti, Abdul Rahman, Aty Widyawaruyanti, Maria Inge Lusida, Achmad Fuad, Soetjipto, Nasronudin, Hiroyuki Fuchino, Nobuo Kawahara, Ikuo Shoji, Lin Deng, Chie Aoki…
    Citation: Virology Journal 2013 10:259
  39. Hepatitis B virus (HBV) infection is a major global health problem. The infectious virion contains an inner “core particle”, which is made of 180 or 240 copies of core protein, alternatively known as hepatitis...

    Authors: Guangyu Xu, Chengguo Wei, Yuqi Guo, Chao Zhang, Nan Zhang and Guoqing Wang
    Citation: Virology Journal 2013 10:256
  40. The disproportionate imbalance between the systemic manifestation of reactive oxygen species and body’s ability to detoxify the reactive intermediates is referred to as oxidative stress. Several biological pro...

    Authors: Usman Zafar Paracha, Kaneez Fatima, Mohammad Alqahtani, Adeel Chaudhary, Adel Abuzenadah, Ghazi Damanhouri and Ishtiaq Qadri
    Citation: Virology Journal 2013 10:251
  41. Hepatitis B virus (HBV) genotype F (HBV/F) is considered to be indigenous to the Americas, but its emergence and spread in the continent remain unknown. Previously, only two HBV/F complete genome sequences fro...

    Authors: Francisco CA Mello, Oscar C Araujo, Barbara V Lago, Ana Rita C Motta-Castro, Marcia Terezinha B Moraes, Selma A Gomes, Gonzalo Bello and Natalia M Araujo
    Citation: Virology Journal 2013 10:236
  42. Little is known about HBV-specific T-cell responses in chronic Hepatitis B patients (HBV) that are co-infected with Human immunodeficiency virus type 1 (HIV-1), especially those with normal alanine aminotransf...

    Authors: Xin Zhang, Hanqian Xing, Xia Feng, Haiping Zhang, Yi Wang and Huiping Yan
    Citation: Virology Journal 2013 10:232